BERTOZZI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.362
EU - Europa 354
AS - Asia 174
AF - Africa 3
SA - Sud America 2
Totale 4.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.362
IT - Italia 152
CN - Cina 132
FI - Finlandia 61
SE - Svezia 46
VN - Vietnam 32
GB - Regno Unito 29
DE - Germania 18
IE - Irlanda 14
NL - Olanda 14
FR - Francia 9
IN - India 5
CH - Svizzera 3
AR - Argentina 2
IL - Israele 2
UA - Ucraina 2
BE - Belgio 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SG - Singapore 1
SM - San Marino 1
TN - Tunisia 1
TW - Taiwan 1
Totale 4.895
Salva come PNG Salva come JPEG
Città #
Fairfield 994
Woodbridge 444
Houston 424
Ashburn 358
Seattle 351
Cambridge 342
Ann Arbor 328
Wilmington 257
Chandler 191
San Diego 106
Princeton 74
Medford 67
Padova 65
Des Moines 44
Beijing 38
Helsinki 34
Dong Ket 32
Nanjing 27
Jacksonville 16
Dublin 14
Roxbury 11
Boardman 10
Jinan 9
Shenyang 9
Hebei 8
Cagliari 6
Falls Church 6
Legnaro 6
London 6
Milan 6
New York 6
Paris 6
Borås 5
Nanchang 5
Dronten 4
Jiaxing 4
Kilburn 4
Ningbo 4
Phoenix 4
Tianjin 4
Verona 4
Cervignano del Friuli 3
Monselice 3
Norwalk 3
Ogden 3
Angri 2
Bridgend 2
Buenos Aires 2
Changsha 2
Chicago 2
Delhi 2
Genoa 2
Hefei 2
Ivrea 2
Kharkiv 2
Kunming 2
Lanzhou 2
New Bedfont 2
Orbetello 2
Palermo 2
Rockville 2
Rome 2
Taiyuan 2
Vechta 2
Acton 1
Ancona 1
Bari 1
Borgo Maggiore 1
Brescia 1
Castel Maggiore 1
Chennai 1
Chiswick 1
Fremont 1
Fulham 1
Groningen 1
Hangzhou 1
Hounslow 1
Indiana 1
Islington 1
Kensington 1
Las Vegas 1
Limbiate 1
Longare 1
Madrid 1
Mahé 1
Monmouth Junction 1
Mumbai 1
Paranaque City 1
Perugia 1
Ploieşti 1
Póvoa de Varzim 1
Redmond 1
Redwood City 1
Roanoke 1
Shanghai 1
Sheffield 1
Siena 1
Singapore 1
Solofra 1
St Louis 1
Totale 4.419
Salva come PNG Salva come JPEG
Nome #
Thrombotic risk correlates with mutational status in true-essential thrombocythemia 125
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 125
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 124
Systemic mastocytosis and essential thrombocythemia: Case report and literature overview 115
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 110
Cardiovascular Events and Intensity of Treatment in Polycythemia Vera 107
Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multi-center Italian study 106
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes 102
Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission 101
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 100
Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients 92
Masked polycythemia Vera (mPV): Results of an international study 90
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 90
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera 89
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 88
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 86
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome 85
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients 85
Effect of busulfan on JAK2V617F allele burden. 85
A 40-years-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosis 83
Pregnancy oucotcome and management of 25 pregnancies in women with polycythemia vera 81
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia. 79
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 79
Idiopathic erythrocytosis: a study of a large cohort with a long follow-up 78
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 78
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia 77
Thrombotic and hemorrhagic complications in idiopathic erythrocytosis 77
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 76
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early /prefibrotic primary myelofibrosis. 75
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia. 75
HFE mutations in idiopathic erythrocytosis 74
Histology of the spleen in Immune Thrombocytopenia: clinical-pathological characterization and prognostic implications 74
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. 73
In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology 73
Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients 73
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 72
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. 71
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 71
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort 69
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study 68
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study 67
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 66
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 65
Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden 64
Thrombotic events in patients with congenital prekallikrein deficiency: A critical evaluation of all reported cases 64
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia 63
Antibiotic use and associated factors in a large sample of hospitalised older people 61
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 61
Development and validation of an International Prognostic Score of thrombosis in WHO-Essential Thrombocythemia (IPSET-thrombosis). 60
Contemporary management of essential thrombocythemia in children 60
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 59
Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency 59
Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues 58
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 55
Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B 54
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 53
Congenital FVII deficiency and thrombotic events after replacement therapy 51
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 51
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 51
Pain and Frailty in Hospitalized Older Adults 46
Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria 42
Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome 41
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 41
Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis 29
Extremely Old Patients Hospitalized in Internal Medicine: What about Their Anemia? 29
Clinical effect of CALR allele burden in patients with essential thrombocythemia 22
A NEW SUSPECTED CAUSE OF ERYTHROCYTOSIS: EPAS1 MUTATIONS ASSOCIATED WITH MUTATIONS IN OTHER GENES 18
Thrombopoietin receptor agonists increase splenic regulatory T-cell numbers in immune thrombocytopenia 17
IDIOPATHIC ERYTHROCYTOSIS WITH THROMBOTIC COMPLICATIONS HAS AN ALTERED BIOMOLECULAR PROFILE 13
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 13
What changed in the Italian internal medicine and geriatric wards during the lockdown 12
Appropriateness of packed red blood cells transfusions in chronic anemic patients in the emergency department: the TRANSFUS-ED retrospective analysis 12
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 10
Essential thrombocythemia in children and adolescents 10
null 9
ERYTHROCYTOSIS AND FAMILIARITY: COEXISTANCE OF MULTIPLE MUTATIONS 8
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 8
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project 5
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 4
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 3
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 3
Coexistence of multiple gene variants in some patients with erythrocytoses: Multiple gene variants in erythrocytosis 2
Targeted NGS analysis reveals a complex genetic background of idiopathic erythrocytosis in a large Venetian family 2
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients 1
Totale 5.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.024
article - articoli 18.410
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019413 0 0 0 0 0 0 0 0 0 82 173 158
2019/20201.110 117 47 15 84 121 81 101 137 163 82 127 35
2020/20211.203 84 108 85 62 58 32 12 90 141 149 83 299
2021/20221.043 77 73 94 95 45 113 46 101 99 42 61 197
2022/2023500 133 16 4 27 82 70 3 52 54 19 26 14
2023/2024244 15 50 47 36 12 20 19 26 15 4 0 0
Totale 5.003